Evogene Schedules Third Quarter 2025 Financial Results Release
Evogene (NASDAQ: EVGN) will release its third quarter 2025 financial results on Thursday, November 20, 2025. Company management will host a Zoom conference call the same day at 9:00 AM ET (4:00 PM Israel time) to discuss the results. Investors must register in advance to attend: https://www.veidan-conferencing.com/evogene. The full conference will be available on the company website a few days after the call.
Evogene (NASDAQ: EVGN) pubblicherà i risultati finanziari del terzo trimestre 2025 il giovedì 20 novembre 2025. La direzione aziendale ospiterà una conference call Zoom nello stesso giorno alle 9:00 AM ET (4:00 PM ora di Israele) per discutere i risultati. Gli investitori devono registrarsi in anticipo per partecipare: https://www.veidan-conferencing.com/evogene. L’intera conferenza sarà disponibile sul sito web dell’azienda pochi giorni dopo la chiamata.
Evogene (NASDAQ: EVGN) divulgará sus resultados financieros del tercer trimestre de 2025 el jueves 20 de noviembre de 2025. La dirección de la empresa realizará una conferencia por Zoom el mismo día a las 9:00 AM ET (4:00 PM hora de Israel) para discutir los resultados. Los inversores deben registrarse con anticipación para asistir: https://www.veidan-conferencing.com/evogene. La conferencia completa estará disponible en el sitio web de la empresa unos días después de la llamada.
에보진(나스닥: EVGN)은 2025년 3분기 재무 실적을 2025년 11월 20일 목요일에 발표합니다. 회사 경영진은 같은 날 줌 컨퍼런스 콜을 동부 표준시 9:00 AM(이스라엘 시간 4:00 PM)에 개최하여 결과를 논의합니다. 투자자는 참석을 위해 미리 등록해야 합니다: https://www.veidan-conferencing.com/evogene. 전체 컨퍼런스는 발표 후 며칠 내에 회사 웹사이트에서 이용 가능하게 됩니다.
Evogene (NASDAQ: EVGN) publikera sina résultats financiers du troisième trimestre 2025 le jeudi 20 novembre 2025. La direction de l'entreprise animera une conférence téléphonique Zoom le même jour à 9h00 ET (16h00 heure d’Israël) pour discuter des résultats. Les investisseurs doivent s’inscrire à l’avance pour y assister : https://www.veidan-conferencing.com/evogene. La conférence complète sera disponible sur le site web de l’entreprise quelques jours après l’appel.
Evogene (NASDAQ: EVGN) wird seine Finanzergebnisse des dritten Quartals 2025 am Donnerstag, dem 20. November 2025 bekannt geben. Die Geschäftsführung wird am selben Tag eine Zoom-Konferenzschaltung um 9:00 Uhr ET (16:00 Uhr israelische Zeit) abhalten, um die Ergebnisse zu besprechen. Investoren müssen sich im Voraus registrieren, um teilzunehmen: https://www.veidan-conferencing.com/evogene. Die vollständige Konferenz wird wenige Tage nach dem Call auf der Unternehmenswebsite verfügbar sein.
Evogene (NASDAQ: EVGN) ستصدر النتائج المالية للربع الثالث من 2025 يوم الخميس 20 نوفمبر 2025. ستستضيف إدارة الشركة مكالمة مؤتمرات Zoom في اليوم نفسه في الساعة 9:00 صباحًا بتوقيت شرق الولايات المتحدة (4:00 مساءً بتوقيت إسرائيل) لمناقشة النتائج. يجب على المستثمرين التسجيل مسبقًا للحضور: https://www.veidan-conferencing.com/evogene. ستتوفر المؤتمر الكامل على موقع الشركة الإلكتروني بعد المكالمة ببضعة أيام.
- None.
- None.
Zoom conference call scheduled for November 20, 2025, 9:00 AM ET
REHOVOT,
Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).
To attend the conference, please register in advance:
https://www.veidan-conferencing.com/evogene
The entire conference will be available online on the company's website a few days after.
About Evogene:
Evogene Ltd. (Nasdaq/TASE: EVGN) is a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries.
At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs.
Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. We call this approach "Real-World Innovation".
Learn more at: www.evogene.com.
Logo: https://mma.prnewswire.com/media/2814604/Evogene_Logo.jpg
Contact:
ir@evogene.com
+972-8-9311901
View original content to download multimedia:https://www.prnewswire.com/news-releases/evogene-schedules-third-quarter-2025-financial-results-release-302607252.html
SOURCE Evogene